There are 2789 resources available
1072P - Primary ipilimumab/nivolumab immunotherapy followed by adjuvant nivolumab in patients with locally advanced or oligometastatic melanoma: Update on outcome
Presenter: Emilia Cocorocchio
Session: ePoster Display
1073P - Quality of life (QOL) endpoints from the phase III intergroup S1404 adjuvant melanoma trial
Presenter: Sapna Patel
Session: ePoster Display
1074P - Italian nivolumab Expanded Access Program (EAP) in melanoma adjuvant setting: Patients outcomes and safety profile
Presenter: Michele Del Vecchio
Session: ePoster Display
1592P - Willingness to vaccinate and side effects of COVID-19 vaccination in patients with breast cancer and gynecological malignancies
Presenter: Marie Forster
Session: ePoster Display
1593P - COVID-19 vaccine acceptance among Tunisian cancer patients: A cross-sectional study
Presenter: Emna Ouertani
Session: ePoster Display
1594P - SARS-CoV-2 vaccines in cancer patients (pts), real-world data (RWD) from 1069 Belong.life users
Presenter: Eli Sapir
Session: ePoster Display
1595P - Acceptance of COVID-19 vaccination among cancer patients in an Irish cancer centre
Presenter: William Mullally
Session: ePoster Display
1518P - Treating cancer with unknown primary (CUP) in Germany – an economic perspective
Presenter: Bernhard Mörtl
Session: ePoster Display
1519TiP - Japanese Society of Medical Oncology/Health Authority of the Japanese Government Cooperative Virtual Educational Program for Improving the Clinical Annotation for Cancer Genomic Medicine
Presenter: Toraji Amano
Session: ePoster Display
1528P - Prospective IAWS registry to optimize either neo- or adjuvant treatment strategies for adult patients with large sized, high grade soft tissue sarcoma (NRSTS)
Presenter: Jörg Hartmann
Session: ePoster Display